-
公开(公告)号：US11912395B2
公开(公告)日：2024-02-27
申请号：US17111405
申请日：2020-12-03
申请人： Attila Nyiri , Robert Cirus , Norbert Cirus
发明人： Attila Nyiri , Robert Cirus , Norbert Cirus
CPC分类号： B64C11/18 , B64C21/02 , B64C2230/20
摘要： The subject of the invention is a propeller blade that has minimal blade tip loss, has a pressure side, opposite to that a suction side, a blade root that can be attached to the propeller and opposite to the blade root a blade tip, where the pressure side is attached to the suction side with a slot that has an inlet opening on the pressure side and an outlet opening on the suction side, and the slot has a pressure equalizing element in it.
Furthermore, the subject of the invention is a propeller that can be used for airplanes, helicopters, horizontal-axis wind turbines, fans and drones and that has at least one propeller blade which is designed according to the first aspect of the invention.-
公开(公告)号：US11819100B2
公开(公告)日：2023-11-21
申请号：US17970098
申请日：2022-10-20
申请人： TODO BIO, S.A.
CPC分类号： A45C11/182 , A45C1/06 , G06Q20/40145 , A45C13/185 , A45C2001/065 , A45C2011/002 , H04W4/80
摘要： A wallet assembly that receives a contactless payment card includes a wallet arranged as at least a bifold wallet with first and second wallet sides, one side configured to receive the contactless card and the other configured to receive additional items and payment cards. RFID shielding eliminates electromagnetic signals from the additional payment cards. A flap attached to the wallet side holding the contactless card has a hole or window that physically exposes a portion of the payment card.
-
公开(公告)号：US11707439B2
公开(公告)日：2023-07-25
申请号：US16840561
申请日：2020-04-06
CPC分类号： A61K31/13 , A61K9/0019 , A61K45/06
摘要： A method and composition is described for treating impaired neurological function, CNS disease or condition, including altered state of consciousness disorders in a human subject, comprising parenterally administering a composition comprising aminoadamantane derivatives or salts thereof, alone or in combination with other neuroprotective and/or anti-inflammatory compounds, in a pharmacologically effective amount. In some embodiments, a method for treating traumatic brain injury caused by a stroke or an accident in a human subject is provided comprising intravenously administering a composition comprising amantadine hydrochloride in a pharmacologically effective amount to the subject in need thereof.
-
公开(公告)号：US10918604B2
公开(公告)日：2021-02-16
申请号：US15742004
申请日：2016-12-16
发明人： Ravikumar Nithiyanandam , Ganesh Vinayak Gat , Dinesh Kumar , Kamal S. Mehta , Premchand Dalichandji Nakhat , Vivek Jain , Priyank Sharma , Baibhav Joshi
摘要： The present invention relates to high drug load pharmaceutical compositions comprising Eslicarbazepine or its pharmaceutically acceptable salts, esters, solvates, polymorphs, enantiomers or mixtures thereof. The present invention also relates to a process for preparing high drug load solid oral pharmaceutical composition comprising Eslicarbazepine acetate and at least one pharmaceutically acceptable excipient. The prior art highlights various technical challenges for formulation development of Eslicarbazepine acetate at lab as well as at industrial scale and offer restrictive and complex approach for resolution of technical challenges. Compositions of Eslicarbazepine acetate prepared as per present invention, wherein disintegrant and/or binder is present in either intra-granular part or in extra-granular part of the composition exhibited desirable technical attributes like comparable dissolution and bioequivalence against reference listed drug.
-
公开(公告)号：US10813916B2
公开(公告)日：2020-10-27
申请号：US15577141
申请日：2016-05-27
发明人： Pankaj Soni , Rashmi Ranjan Panda , Ganesh Vinayak Gat , Dinesh Kumar , Kamal S. Mehta , Ravikumar Nithiyanandam
IPC分类号： A61K31/433 , A61K9/16 , A61K9/48
摘要： The present invention relates to an immediate release solid oral pharmaceutical composition comprising an effective amount of Tizanidine or its pharmaceutically acceptable salts, esters, solvates, polymorphs, stereoisomers or mixtures thereof. The solid oral dosage form comprises one or more methacrylic acid copolymers or its derivatives and is bioequivalent to the commercially available counterpart (ZANAFLEX® capsule) after oral administration. The invention also relates to a process for preparation of a pharmaceutical capsule dosage form comprising an effective amount of Tizanidine Hydrochloride wherein, the dosage form comprises methacrylic acid copolymer or its derivatives.
-
公开(公告)号：US10577611B2
公开(公告)日：2020-03-03
申请号：US14249533
申请日：2014-04-10
申请人： DSM IP ASSETS B.V.
摘要： The present invention relates to polynucleotide sequences which enable a polynucleotide control sequence, such as a promoter, to direct expression in a wide range of industrially relevant species, both prokaryotes and eukaryotes. When the polynucleotide sequences of the invention are applied in combination with selection marker genes it is possible to perform selectable cloning in a laboratory host and use the same construct in the final host.
-
-
-
-
公开(公告)号：US09883708B2
公开(公告)日：2018-02-06
申请号：US13889002
申请日：2013-05-07
申请人： Sondra Lewis , Alexis McKenzie
发明人： Sondra Lewis , Alexis McKenzie
CPC分类号： A42B1/004 , A44C15/006
摘要： The invention relates to a head covering such as a tiara having a display element attached thereon which may be easily interchanged by the user to increase the versatility of the head covering and allow the user to switch in display elements having varying shapes and sizes. The head coverings may be used by adults at sporting events and/or by children playing dress-up, for example.
-
-
-
-
-
-
-
-
-
搜索结果
242 条记录 (耗时 0.024 秒)
